Spinal Stenosis

TAICHUNG, Oct. 10, 2024 /PRNewswire/ -- China Medical University Hospital (CMUH, Taiwan) continues to make significant strides in cell therapy, demonstrating its leadership on the global stage. Ms. Lin, a patient with malignant glioma, underwent tumor removal surgery followed by radiation therapy and dendritic cell immunotherapy. After four years of follow-up, her condition remains stable, and she maintains an excellent quality of life. Continue Reading Dr. Chen Chun-Chung (right), Chief of CMUH’s Neurosurgery Department, representing the Taiwan Neurosurgical Society, signed an MOU with Prof. Dato Dr. Abdul Rahman Izaini Ghani, President of the Neurosurgical Association of Malaysia, in Kuching, Malaysia. This agreement makes a significant milestone in neurosurgical collaboration between Taiwan and Malaysia, offering Malaysian neurosurgeons streamlined access to Taiwan’s advanced medical technologies. "Malignant gliomas are notoriously challenging to treat," said Dr. Chen Chun-Chung, Director of Neurosurgery at CMUH. "Thanks to Ms. Lin's positive attitude and the advanced cell therapy, we've achieved promising outcomes." On September 14, three CMUH physicians were invited to speak at the Sarawak Neurosurgery Update & Neurosurgical Association of Malaysia Annual Scientific Meeting 2024 (NAM-SNU ASM 2024). Dr. Chen Chun-Chung highlighted the success of CMUH's cell therapy, while representatives from the Taiwanese and Malaysian Neurosurgical Societies signed a Memorandum of Understanding (MOU), strengthening medical exchange and collaboration between the two countries. Taiwan's First Participation in NAM-SNU ASM: A Milestone in Taiwan-Malaysia Medical Exchange Following the successful "Taiwan-Malaysia Neurosurgery Advanced Medical Summit 2024" in July, Taiwan made its debut participation at NAM-SNU ASM 2024. Dr. Chen Chun-Chung, alongside Dr. Brian Chiu Cheng-Di, Director of Minimally Invasive Spine Neurosurgery, and Dr. Chuang Hao-Yu, Director of the Cell Therapy Center at Tainan City An Nan Hospital, were invited to present at the conference. This marked the first time Taiwanese physicians participated in the event. The MOU signed between the Taiwan Neurosurgical Society (TNS) and the Neurosurgical Association of Malaysia (NAM) is seen as a key development in Taiwan-Malaysia neurosurgical collaboration. Cutting-edge Neurosurgical Techniques Spark Interest from Malaysian Physicians At CMUH physicians presented on cutting-edge neurosurgical techniques, including treatments for brain cancer, stroke, and endoscopic spine surgery. Their presentations attracted significant attention and sparked enthusiastic discussions among conference attendees. Dr. Chen shared the success story of Ms. Lin, diagnosed with malignant glioma in 2000 after experiencing seizures. Despite the challenges of treating this aggressive brain cancer, Ms. Lin underwent surgery, radiation therapy, and dendritic cell immunotherapy, receiving ten vaccine injections. Her progress has been closely monitored for over four years, showing significant improvement. Dr. Chen highlighted those traditional treatments for malignant glioma, primarily radiation and limited targeted therapies, offer an average survival rate of just 15 months. However, at CMUH, the average survival has risen to 23 months, with Ms. Lin surpassing the four-year milestone. CMUH's cell therapy program is now advancing into CAR-T cell therapy, promising even better outcomes for cancer patients. "We are excited to share our clinical experience in cell therapy with our Malaysian colleagues and continue to promote the exchange of medical expertise," said Dr. Chen. Dr. Brian Chiu Cheng-Di highlighted Taiwan's extensive clinical experience in endoscopic spine surgery, which allows for minimally invasive procedures with faster recovery times. The technique is especially beneficial for spinal disc removal, spinal stenosis, and tumor surgeries, though more careful assessment is required for cases involving structural abnormalities or malignancies. Following Dr. Chiu's presentation, three Malaysian experts signed up for advanced training in Taiwan. Dr. Chuang Hao-Yu presented on two key areas of Taiwan's neurosurgery advancements. The first focused on intracerebral hemorrhagic stroke, which has a higher incidence in Asia than in Western countries, and how Taiwan's minimally invasive surgery techniques significantly reduce mortality and neurological disabilities. The second highlighted Taiwan's progress in interventional vascular treatments, developed through collaborative efforts of six major medical societies. Strengthening Taiwan-Malaysia Medical Cooperation Chou Aichi, CEO of CMUH's International Center, emphasized that neurosurgery has been a focal point for Taiwan-Malaysia medical exchanges for the past three years under the Ministry of Health and Welfare's "New Southbound Medical and Health Cooperation and Industry Development" initiative. The partnership includes seminars, hospital visits, health lectures, and physician training in Taiwan. At this year's conference, Taiwanese companies Brain Navi Biotechnology and EPED Inc. showcased Taiwan's cutting-edge medical technologies. The MOU signed between TNS and NAM strengthens opportunities for Malaysian neurosurgeons to benefit from Taiwan's advanced innovations. This collaboration marks a significant milestone in Taiwan's New Southbound Policy, further promoting medical partnerships across Southeast Asia. Contact: Carolyn Chen [email protected] SOURCE China Medical University Hospital WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

CINCINNATI, Oct. 7, 2024 /PRNewswire/ -- Integrated Pain Solutions (IPS), together with American Pain Consortium (APC), are excited to announce a significant milestone in their mission to enhance Interventional Pain Management. As a leading provider of Interventional Pain Management (IPM) services, IPS announced today the addition of Cincinnati Comprehensive Pain Center to their advanced network of IPM practices. Adding to IPS's existing locations in Columbus, Dublin, and Springfield, Ohio, this partnership grows IPS's total number of clinics to four and expands its footprint to Cincinnati, allowing IPS to serve a broader patient base and meet the growing demand for state-of-the-art, personalized, and comprehensive pain care. This strategic partnership reaffirms IPS's dedication to providing exceptional, individualized patient care by industry-leading interventional pain physicians. Leading the facility is Dr. Humam Akbik, who is fellowship trained in Interventional Pain Medicine through the Brigham and Women's Hospital at Harvard Medical School in Boston, MA where he also completed his residency in Anesthesiology. Dr. Akbik brings almost three decades of experience as an Interventional Pain Medicine specialist, employing a multidisciplinary & comprehensive approach to the treatment of pain. A demonstrated expert in minimally invasive spine surgery, Dr. Akbik believes in offering a wide range of effective therapies tailored to meet the needs of each patient. As part of the IPS network, Dr. Akbik now receives essential management support provided by American Pain Consortium. APC supports a growing network of interventional pain management practices and pain-focused ambulatory surgical centers (ASC) that provide state-of-the-art, patient-focused support services. "We are absolutely thrilled and proud to welcome Dr. Humam Akbik, a leader of Interventional Pain care to our team," said Sean Hayes, President of American Pain Consortium. "This is a monumental moment for us as we join forces with such an exceptional expert in pain management. Dr. Akbik's unparalleled expertise and innovative approaches will drive our mission forward and elevate our ability to provide transformative care. We are excited about the incredible advancements we will achieve together and the profound impact this collaboration will have on patients' lives." Similarly to all IPS clinics, the new Cincinnati clinic will provide comprehensive pain management services that include minimally invasive procedures, physical therapy, and psychological services. Finding an effective treatment for pain can often be a difficult and emotional journey for many patients. At Integrated Pain Solutions, patients can find comprehensive and personalized treatments for a diverse range of painful conditions. Patients can find resources to confront common sources of chronic pain including back or neck pain, degenerative disc disease, spinal stenosis, neuropathic pain, and complex regional pain syndromes (CRPS), and more. IPS's interventional pain clinics also provide services for patients suffering from other musculoskeletal related sports injuries, work accidents, or other injuries. Treatments at Integrated Pain Solutions include a variety of injections, spinal stimulators, pain pumps, PRP therapy, diagnostic imaging, physical therapy, psychological counseling, and limited medication management. IPS's full suite of comprehensive services allows for a patient's pain management plan to evolve as their needs change. Patients can come to one convenient clinic to be evaluated, diagnosed, and treated. IPS is now accepting new patients at its new Cincinnati location, as well as its Columbus, Dublin, and Springfield locations. Schedule your visit at . Contact American Pain Consortium at SOURCE Integrated Pain Solutions WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. “The acquisition of Vertos Medical enhances our unique, non-surgical solutions for interventionalists addressing chronic lower back pain, while broadening our presence in ambulatory surgery centers,” said Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker. “We look forward to enabling physicians with the minimally invasive mild ® procedure so patients can reclaim their quality of life.” The addition of Vertos Medical’s differentiated portfolio will strengthen Stryker’s impact in interventional solutions to address chronic pain. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at . Media contact Beth Sizemore Sr. Director, Strategic Communications beth.sizemore@stryker.com